Article info

Original research
Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination

Authors

  • Chung-Hsiung Huang Department of Food Science, National Taiwan Ocean University, Keelung, Taiwan PubMed articlesGoogle scholar articles
  • Chiung-Yi Huang National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan PubMed articlesGoogle scholar articles
  • Hui-Min Ho National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan PubMed articlesGoogle scholar articles
  • Ching-Hung Lee National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan PubMed articlesGoogle scholar articles
  • Pang-Ti Lai National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan PubMed articlesGoogle scholar articles
  • Suh-Chin Wu Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan PubMed articlesGoogle scholar articles
  • Shih-Jen Liu National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Ming-Hsi Huang National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ming-Hsi Huang; huangminghsi{at}nhri.org.tw
View Full Text

Citation

Huang C, Huang C, Ho H, et al
Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination

Publication history

  • Accepted August 28, 2020
  • First published October 9, 2020.
Online issue publication 
October 09, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.